Table 2. Univariate and Multivariate analysis for overall survival.
| Variable | Univariate (95% CI) | P | Multivariate (95% CI) | P |
|---|---|---|---|---|
| Type health coverage (public) | 1.92 (1.25-2.94) | 0.003 | 1.61 (1.01-2.56) | 0.047 |
| No prior nephrectomy | 2.47 (1.46-4.17) | 0.001 | 1.21 (0.64-2.29) | 0.56 |
| IMDC poor risk | 3.80 (2.37-6.06) | <0.001 | 3.15 (1.79-5.53) | <0.001 |
| ECOG ≥2 | 3.43 (2.15-5.45) | <0.001 | 1.81 (1.02-3.22) | 0.04 |
| Synchronic metastasis | 1.56 (1.07-2.26) | 0.02 | 1.32 (0.86-2.03) | 0.21 |
| ≥2 sites metastasis | 2.02 (1.28-3.20) | 0.0030 | 2.81 (1.67-4.71) | <0.001 |
| Non-clear cell histology | 1.51 (0.94-2.44) | 0.09 |
ECOG = Eastern Cooperative Oncology; IMDC = International Metastatic Renal Cell Carcinoma Database Consortium risk model classification; 95% CI = 95% Confidence Interval